AI has fundamentally altered the feasibility of natural product discovery from fungal endophytes. Advances in genome sequencing, metabolomics, and systems biology have generated vast datasets, but ...

The Computational Analysis of Novel Drug Opportunities (CANDO) platform is a computational approach to make drug discovery faster and less expensive while also being safe and effective. According to ...

A research team from the University of Oklahoma has pioneered a groundbreaking method that could accelerate drug discovery and reduce pharmaceutical development costs. Their work, published in the ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory in Singapore, ...

Located at the cellular interface, membrane proteins play critical regulatory roles in the signaling between a cell and its interacting environment, making them popular and ideal drug targets.

AI is everywhere these days, and though there’s debate about how useful it is, one area where experts think it could be game-changing is scientific research. It promised to be particularly useful for ...

Headshot of Sumit Chanda standing outside Scripps Research Institute. Sumit Chanda has dedicated his career to antiviral drug research. Credit: Courtesy of the Chanda Lab The US National Institutes of ...

GUEST COMMENTARY—During a recent venture capital class, I was asked: what percentage of a biotech startup’s equity should a university retain when it is the company’s founders who conceive the key ...

The Ontario Institute for Cancer Research (OICR) has announced its support for five Ontario research teams working to develop the next generation of medicines that kill tumours more effectively, cause ...

CEO Ramy Farid highlighted strong Q1 performance, reporting total revenue of $59.6 million, driven by $48.8 million in software revenue with 46% growth and $10.7 million in drug discovery revenue.